PTC Therapeutics Inc (NASDAQ:PTCT)
| 47.50 Delayed Data As of Apr 09 |  -0.76 / -1.57%Today’s Change | 43.65 Today|||52-Week Range 70.82 | -22.17% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 36.8M | 82.7M | 194.4M | 264.7M | |
| Cost of Goods Sold | -- | -- | 2.3M | 9.5M | ||
| Depreciation And Amortization | 2.9M | 3.3M | 17.7M | 26.1M | ||
| Operating Expenses | Gross Income | -- | -- | 174.4M | 229.2M | |
| General Expenses | 201.0M | 209.0M | 238.7M | 323.8M | ||
| Research And Development | 121.8M | 117.6M | 117.5M | 172.0M | ||
| Total Operating Expenses | 203.9M | 212.3M | 258.7M | 359.4M | ||
| Non-Operating Expenses | Operating Income | -167.1M | -129.6M | -64.3M | -94.6M | |
| Extraordinary Credit | 140.0K | 47.0K | 0.00 | 0.00 | ||
| Extraordinary Charge | 0.00 | -2.5M | 0.00 | -21.0M | ||
| Interest Expense On Debt | 2.4M | 8.3M | 12.1M | 12.6M | ||
| Other Expenses | -605.0K | -1.3M | -1.3M | 129.0K | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -170.0M | -141.5M | -77.7M | -128.1M | |
| Income Taxes | -485.0K | -569.0K | -1.3M | -29.0K | ||
| Net Income | -170.4M | -142.1M | -79.0M | -128.1M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 33.6M | 34.0M | 39.2M | 46.6M | |
| Shares To Calculate EPS Diluted | 33.6M | 34.0M | 39.2M | 46.6M | ||
| Earnings Per Share | EPS | -$5.07 | -$4.17 | -$2.02 | -$2.75 | |
| EPS Diluted | -$5.07 | -$4.17 | -$2.02 | -$2.75 | ||
